Advanced Breast Cancer
Also known as: Malignant neoplasm of breast / Malignant breast neoplasm / Breast cancer / Breast tumor malignant / Breast tumour malignant / Breast cancer NOS / Breast cancer stage unspecified / Ca breast
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01217 | Anastrozole | A competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women. |
| DB06374 | Elacestrant | An estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. |
| DB00947 | Fulvestrant | An estrogen receptor antagonist used to treat HR+ breast cancer that may also be HER2-. |
| DB00014 | Goserelin | A synthetic analog of luteinizing hormone-releasing hormone used to treat breast cancer and prostate cancer by reducing secretion of gonadotropins from the pituitary. |
| DB01006 | Letrozole | An aromatase inhibitor used to treat breast cancer in postmenopausal women. |
| DB09073 | Palbociclib | An endocrine-based chemotherapeutic agent used in combination with other antineoplastic agents to treat HER2-negative and HR-positive advanced or metastatic breast cancer. |
| DB11730 | Ribociclib | A kinase inhibitor used to treat HR+, HER2- advanced or metastatic breast cancer. |